Nothing Special   »   [go: up one dir, main page]

Donmez et al., 2010 - Google Patents

MRI features of posterior reversible encephalopathy syndrome in 33 patients

Donmez et al., 2010

Document ID
12530860177519851483
Author
Donmez F
Basaran C
Kayahan Ulu E
Yildirim M
Coskun M
Publication year
Publication venue
Journal of Neuroimaging

External Links

Snippet

ABSTRACT BACKGROUND AND PURPOSE We report the clinical and radiological features of posterior reversible encephalopathy and compare our findings to the literature. METHODS The brain magnetic resonance imaging and clinical records of 33 patients were …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences, Generation or control of pulse sequences ; Operator Console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/563—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution of moving material, e.g. flow contrast angiography
    • G01R33/56341—Diffusion imaging
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences, Generation or control of pulse sequences ; Operator Console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/4808—Multimodal MR, e.g. MR combined with positron emission tomography [PET], MR combined with ultrasound or MR combined with computed tomography [CT]
    • G01R33/481—MR combined with positron emission tomography [PET] or single photon emission computed tomography [SPECT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital

Similar Documents

Publication Publication Date Title
Donmez et al. MRI features of posterior reversible encephalopathy syndrome in 33 patients
Wilson et al. Infratentorial superficial siderosis: classification, diagnostic criteria, and rational investigation pathway
Stott et al. Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed
Liu et al. Diffuse axonal injury after traumatic cerebral microbleeds: an evaluation of imaging techniques
Soyer et al. Observational study on the safety profile of gadoterate meglumine in 35,499 patients: The SECURE study
Splendiani et al. Contrast-enhanced FLAIR in the early diagnosis of infectious meningitis
Martucci et al. Cerebral amyloid angiopathy-related inflammation: imaging findings and clinical outcome
da Rocha et al. Comparison of magnetic resonance imaging sequences with computed tomography to detect low-grade subarachnoid hemorrhage: role of fluid-attenuated inversion recovery sequence
Eisele et al. Investigation of leptomeningeal enhancement in MS: a postcontrast FLAIR MRI study
Gao et al. Association of degree and type of edema in posterior reversible encephalopathy syndrome with serum lactate dehydrogenase level: initial experience
Küker et al. Progressive multifocal leukoencephalopathy: value of diffusion‐weighted and contrast‐enhanced magnetic resonance imaging for diagnosis and treatment control
Pinto et al. Acute hemorrhagic leukoencephalitis with severe brainstem and spinal cord involvement: MRI features with neuropathological confirmation
Boulouis et al. Magnetic resonance imaging arterial‐spin‐labelling perfusion alterations in childhood migraine with atypical aura: a case–control study
Gungor et al. Early and late neurological complications of liver transplantation in pediatric patients
Dedić Plavetić et al. Fatal outcome of posterior “reversible” encephalopathy syndrome in metastatic colorectal carcinoma after irinotecan and fluoropyrimidine chemotherapy regimen
Rangi et al. Posterior reversible encephalopathy syndrome: a possible late interaction between cytotoxic agents and general anaesthesia
Norman et al. Reversible posterior leukoencephalopathy syndrome in children undergoing induction therapy for acute lymphoblastic leukemia
McWilliams et al. Observational study on the incidence of nephrogenic systemic fibrosis in patients with renal impairment following gadoterate meglumine administration: the NSsaFe study.
Löbel et al. Cerebral magnetic resonance imaging findings in adults with haemolytic uraemic syndrome following an infection with Escherichia coli, subtype O104: H4
Lin et al. Association between peripheral oxidative stress and white matter damage in acute traumatic brain injury
Deep et al. Magnetic resonance imaging assessment of vascular contact of the facial nerve in the asymptomatic patient
Alkan et al. Brain perfusion MRI findings in patients with Behcet’s disease
Joo et al. Assessment of meningeal lymphatics in the parasagittal dural space: a prospective feasibility study using dynamic contrast-enhanced magnetic resonance imaging
Khan et al. Detecting the uncommon imaging manifestations of posterior reversible encephalopathy syndrome (PRES) in adults: a comprehensive illustrated guide for the trainee radiologist
Uruha et al. Unusual presentation of sarcoidosis: solitary intracranial mass lesion mimicking a glioma